Home / Citalopram / Canada
CA ATC N06AB04 · updated 2 Nov 2026
Citalopram shortage in Canada
Is there a Citalopram shortage in Canada?
Yes. As of 2 Nov 2026, 12 Citalopram products are reported short in Canada, the first since 15 Jun 2017. The company estimate for the return is 30 Nov 2026 (latest 12 Feb 2027). Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | SEPTA-CITALOPRAM (100s) | SEPTA PHARMACEUTICALS INC | 15 Jun 2017 | not given | Other Other (Please describe in comments) |
| CA | BIO-CITALOPRAM (100) | BIOMED PHARMA | 29 Aug 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | BIO-CITALOPRAM (100) | BIOMED PHARMA | 20 Mar 2019 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | BIO-CITALOPRAM (3x10) | BIOMED PHARMA | 20 Mar 2019 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | BIO-CITALOPRAM (3x10) | BIOMED PHARMA | 9 Jul 2019 | not given | Increased demand Demand increase for the drug |
| CA | SEPTA-CITALOPRAM (100s and 500s) | SEPTA PHARMACEUTICALS INC | 21 May 2020 | not given | Other Other (Please describe in comments) |
| CA | SEPTA-CITALOPRAM (100s) | SEPTA PHARMACEUTICALS INC | 21 May 2020 | not given | Other Other (Please describe in comments) |
| CA | NRA-CITALOPRAM (100's) | NORA PHARMA INC | 1 Sep 2025 | 30 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-CITALOPRAM (30's, 500's) | NORA PHARMA INC | 1 Sep 2025 | 30 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-CITALOPRAM (30 BLS) | APOTEX INC | 27 Oct 2026 | 4 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | CITALOPRAM (2900) anticipated | SANIS HEALTH INC | 20 Nov 2026 | 12 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-CITALOPRAM (30's, 500's) anticipated | NORA PHARMA INC | 10 Dec 2026 | 30 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.